Air Methods selected by US Air Force:
This article was originally published in Clinica
Executive Summary
Air Methods has been selected as a prime contractor by the US Air Force Human Systems Center to develop and manufacture a new generation spinal cord injury transport system (SCITS). The agreement will result in a platform and stretcher for the aeromedical evacuation and care of spinal cord injury, burn and trauma patients. Total revenues could be over $9 million by 2002. Air Methods could generate more revenues as it retains the intellectual property rights to its technology and could also sell in the commercial and foreign military markets.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.